ABYEX
Price
$11.92
Change
+$0.16 (+1.36%)
Updated
Jul 31 closing price
Net Assets
172.94M
RNWAX
Price
$100.62
Change
+$1.94 (+1.97%)
Updated
Jul 31 closing price
Net Assets
90.71B
Interact to see
Advertisement

ABYEX vs RNWAX

ABYEX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
ABYEX vs. RNWAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABYEX is a Buy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 90.7B vs. ABYEX (173M). ABYEX pays higher dividends than RNWAX: ABYEX (2.69) vs RNWAX (0.50). ABYEX was incepted earlier than RNWAX: ABYEX (15 years) vs RNWAX (24 years). RNWAX (1.66) is less costly to investors than ABYEX (1.40). ABYEX is a more actively managed with annual turnover of: 135.00 vs. RNWAX (46.00). ABYEX has a lower initial minimum investment than RNWAX: ABYEX (0) vs RNWAX (250). ABYEX annual gain was more profitable for investors over the last year : 28.94 vs. RNWAX (20.44). ABYEX return over 5 years is better than : 40.87 vs. RNWAX (12.95).
ABYEXRNWAXABYEX / RNWAX
Total Expense Ratio1.001.6660%
Annual Report Gross Expense Ratio1.401.6684%
Fund Existence15 years24 years-
Gain YTD17.04013.362128%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets173M90.7B0%
Annual Yield % from dividends2.690.50541%
Returns for 1 year28.9420.44142%
Returns for 3 years72.3339.97181%
Returns for 5 years40.8712.95316%
Returns for 10 years92.2998.5294%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLIQX26.560.23
+0.87%
Lone Peak Value Super Institutional
PRPCX5.410.03
+0.56%
PGIM Jennison Energy Infrastructure C
IGA10.210.04
+0.39%
Voya Global Advantage AND Premium Opportunity Fund
TBLIX37.580.14
+0.37%
Transamerica Multi-Managed Balanced I
FTXH38.89-0.41
-1.05%
First Trust Nasdaq Pharmaceuticals ETF